$1.97
0.0699[3.68%]
At close: Apr 24
$1.97
0[0.00%]
After Hours: 8:04AM EDT
Arcadia Biosciences
(NASDAQ:RKDA)Arcadia Biosciences Stock (NASDAQ:RKDA), Insider Trading Activity
Arcadia Biosciences: Insider buying and selling updated today.
Insider Shares Owned
214.787K
Insider Percentage Owned
19.3%
Institutional Shares Held
10.835K
Institutional Percentage Held
0.80%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05, 2024 | Thomas J Schaefer | CHIEF FINANCIAL OFFICER | 700 | $2.06 | $1.44K | BUY | 97.36% | 1.419K | Feb 01 | View |
| Aug 07, 2023 | Thomas J Schaefer | CHIEF FINANCIAL OFFICER | 649 | $3.67 | $2.38K | BUY | 927.14% | 719 | Aug 04 | View |
| May 30, 2023 | Stanley E. Jacot Jr., | CHIEF EXECUTIVE OFFICER | 5K | $4.31 | $21.55K | BUY | ∞ | 5K | May 30 | View |
| Feb 02, 2023 | Thomas Schaefer | CHIEF FINANCIAL OFFICER | 700 | $0.23 | $161.00 | BUY | 33.33% | 2.8K | Feb 01 | View |
| Aug 03, 2022 | Pamela Haley | CHIEF FINANCIAL OFFICER | 700 | $0.70 | $490.00 | BUY | 15.95% | 5.088K | Aug 01 | View |
| Jan 25, 2021 | Matthew Plavan | CHIEF EXECUTIVE OFFICER | 585 | $3.16 | $1.85K | BUY | 4.27% | 14.285K | Aug 03 | View |
| Jan 25, 2021 | Randall Shultz | CHIEF TECHNOLOGY OFFICER | 700 | $3.16 | $2.21K | BUY | 5.69% | 13K | Aug 03 | View |
| Jan 25, 2021 | Pamela Haley | CHIEF FINANCIAL OFFICER | 700 | $3.16 | $2.21K | BUY | 36.12% | 2.638K | Aug 03 | View |
| Feb 04, 2020 | Pamela Haley | 700 | $1.72 | $1.20K | PURCHASE | 56.54% | 1.938K | Feb 03 | View | |
| Feb 04, 2020 | Sarah Reiter | 700 | $1.72 | $1.20K | PURCHASE | 22.58% | 3.8K | Feb 03 | View | |
| Feb 04, 2020 | Matthew Plavan | 700 | $1.72 | $1.20K | PURCHASE | 5.38% | 13.7K | Feb 03 | View | |
| Dec 23, 2019 | Sarah Reiter | CHIEF COMMERCIAL OFFICER | 900 | $5.95 | $5.36K | BUY | 40.91% | 3.1K | Dec 23 | View |
| Nov 20, 2019 | Sarah Reiter | CHIEF COMMERCIAL OFFICER | 1K | $4.52 | $4.52K | BUY | 83.33% | 2.2K | Nov 19 | View |
| Nov 19, 2019 | Lilian Shackelford Murray | DIRECTOR | 5K | $4.25 | $21.25K | BUY | 141.88% | 8.524K | Nov 18 | View |
| Nov 18, 2019 | Matthew T Plavan | CHIEF EXECUTIVE OFFICER | 1K | $4.08 | $4.08K | BUY | 8.33% | 13K | Nov 14 | View |
| Sep 23, 2019 | Matthew T Plavan | CHIEF EXECUTIVE OFFICER | 2K | $5.25 | $10.50K | BUY | 20.00% | 12K | Sep 23 | View |
| Sep 17, 2019 | Kevin Comcowich | DIRECTOR | 5K | $5.88 | $29.39K | BUY | 33.33% | 20K | Sep 17 | View |
| Sep 10, 2019 | Matthew T Plavan | CHIEF EXECUTIVE OFFICER | 2K | $6.51 | $13.01K | BUY | 25.00% | 10K | Sep 10 | View |
| Sep 10, 2019 | Sarah Reiter | CHIEF COMMERCIAL OFFICER | 1.2K | $6.48 | $7.78K | BUY | ∞ | 1.2K | Sep 10 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.